SEGALL BRYANT & HAMILL, LLC – Novo Nordisk A/S Transaction History
SEGALL BRYANT & HAMILL, LLC portfolio value:
$25.69M
portfolio value
SEGALL BRYANT & HAMILL, LLC quarter portfolio value change:
-10.59%
quarter
Novo Nordisk A/S 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +9064.46% | 256.07K shares | 25.37M | $99.63 | 258.89K |
| Q2 2022 | share | 0.00% | 0 shares | 1K | $111.43 | 2.82K | |
| Q1 2022 | share | Increase | 0.00% | 2.82K shares | 314K | $111.05 | 2.82K |
| Q4 2021 | share | Decrease | -100.00% | -2.90K shares | -278K | $111.45 | 0 |
| Q3 2021 | share | Increase | +10.67% | 280 shares | 58K | $96.01 | 2.90K |
| Q2 2021 | share | Increase | 0.00% | 2.62K shares | 220K | $83.32 | 2.62K |